BioHealth News Archive

Sirnaomics to spin off RNAimmune to develop novel mRNA therapeutics and vaccines – Maryland Daily Record

Sirnaomics to spin off RNAimmune to develop novel mRNA therapeutics and vaccines – Maryland Daily Record

Sirnaomics Inc., a Gaithersburg-based biopharmaceutical company engaged in the discovery and development of RNAi therapeutics, Friday announced a corporate technology spinoff establishing an independent…

Read More
FDA Grant and Gift from Entrepreneur Provide $250K in Awards for Pediatric Medical Device Competition Focused on COVID-19 Innovations | Benzinga

FDA Grant and Gift from Entrepreneur Provide $250K in Awards for Pediatric Medical Device Competition Focused on COVID-19 Innovations | Benzinga

WASHINGTON, June 11, 2020 /PRNewswire/ -- As medical data increasingly highlights the serious impact of COVID-19 on children's health, the National Capital Consortium for Pediatric Device…

Read More
BRIEF-Novo Nordisk To Acquire Corvidia Therapeutics – Reuters – congrats to Ram Aiyar former BHI EIR

BRIEF-Novo Nordisk To Acquire Corvidia Therapeutics – Reuters – congrats to Ram Aiyar former BHI EIR

* NOVO NORDISK TO ACQUIRE CORVIDIA THERAPEUTICS AND EXPAND PRESENCE IN CARDIOVASCULAR DISEASE * UNDER TERMS OF AGREEMENT, NOVO NORDISK WILL ACQUIRE ALL OUTSTANDING…

Read More
Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) Nasdaq:VIE

Viela Bio Announces U.S. FDA Approval of UPLIZNA™ (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) Nasdaq:VIE

GAITHERSBURG, Md., June 11, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNATM…

Read More
Emmes Announces Its Work on a Phase 3 Clinical Trial for Breakthrough Therapy Designation Product | BioSpace

Emmes Announces Its Work on a Phase 3 Clinical Trial for Breakthrough Therapy Designation Product | BioSpace

ROCKVILLE, Md., June 15, 2020 /PRNewswire/ -- Emmes Group today announced that it provided the Phase 3 clinical trial support for a new investigational cell therapy…

Read More
Charlottesville company develops test to predict most severe cases of COVID-19

Charlottesville company develops test to predict most severe cases of COVID-19

CHARLOTTESVILLE, Va. (WVIR) - The COVID-19 pandemic has presented many complex challenges to those in the medical field. One Charlottesville-based company stepped up to…

Read More
The Top Biotech Companies That are Hiring – June 2020 · BioBuzz

The Top Biotech Companies That are Hiring – June 2020 · BioBuzz

Despite the uncertainty created by the COVID-19 pandemic, companies across the BioHealth Capital Region (BHCR) continue to hunt for talented life science professionals to…

Read More
2020 Life Science Venture Capital Funding Roundup for Q1/Q2 in the BioHealth Capital Region · BioBuzz

2020 Life Science Venture Capital Funding Roundup for Q1/Q2 in the BioHealth Capital Region · BioBuzz

This has certainly been a year unlike any other for BioHealth Capital Region (BHCR) life science companies of all sizes and kinds. Just a…

Read More
FSIF COVID BIOSCIENCE APPLIES FOR PATENT ON INNOVATIVE NEW COVID-19 TEST

FSIF COVID BIOSCIENCE APPLIES FOR PATENT ON INNOVATIVE NEW COVID-19 TEST

<p>Cambridge, MD, June 15 — FSIF COVID BioScience, a biotechnology company focused on harnessing the power of the human immune system to diagnosis and…

Read More
Virginia Based AMPEL BioSolutions’ Technology Predicts Severity of Illness in COVID19 Patients and Identifies Treatments

Virginia Based AMPEL BioSolutions’ Technology Predicts Severity of Illness in COVID19 Patients and Identifies Treatments

Charlottesville, Virginia. June 9, 2020. AMPEL BioSolutions announces genomic analysis and findings that could improve treatment of COVID19 patients with approved drugs such as…

Read More
Anthony D. Saleh, Ph.D., CEO of miRecule, joins Rich Bendis on BioTalk

Anthony D. Saleh, Ph.D., CEO of miRecule, joins Rich Bendis on BioTalk

miRecule CEO Anthony D. Saleh, Ph.D. guests on BioTalk to discuss his company, his many roles in startup companies, and being an Entrepreneur in…

Read More
Sign Up Now – June EIR Feedback Session

Sign Up Now – June EIR Feedback Session

Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your complimentary…

Read More
Sign Up Now – June EIR Feedback Session – Only one spot left!

Sign Up Now – June EIR Feedback Session – Only one spot left!

Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your complimentary…

Read More
Novavax awarded $60M Department of Defense contract for Covid-19 vaccine – Washington Business Journal

Novavax awarded $60M Department of Defense contract for Covid-19 vaccine – Washington Business Journal

Novavax Inc. just scored even more support for its coronavirus vaccine program. The Gaithersburg company said late Thursday it won a Department of Defense…

Read More
AstraZeneca Ranked Most Inventive, Roche Most Innovative

AstraZeneca Ranked Most Inventive, Roche Most Innovative

AstraZeneca (AZN) was ranked the most the most inventive pharmaceutical company for the second year in a row by IDEA Pharma's Invention and Innovation…

Read More